Literature DB >> 15729726

Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma.

Takafumi Sangai1, Genichiro Ishii, Keiji Kodama, Shin'ichi Miyamoto, Yasuyuki Aoyagi, Takashi Ito, Junji Magae, Hiroki Sasaki, Takeshi Nagashima, Masaru Miyazaki, Atsushi Ochiai.   

Abstract

Cancer-stromal interaction is well known to play important roles during cancer progression. Recently we have demonstrated that bone marrow-derived vascular endothelial cells (BMD-VE) and myofibroblasts (BMD-MF) are recruited into the human pancreatic cancer cell line Capan-1 induced stroma. To assess the effect of the difference in cancer cell types on the recruitment of BMD-VE and BMD-MF, 10 kinds of human cancer cell line were implanted into the subcutaneous tissue of the immunodeficient mice transplanted with bone marrow of double-mutant mice (RAG-1-/- beta-gal Tg or RAG-1-/- GFP Tg). The recruitment frequency of BMD-VE (%BMD-VE) and BMD-MF (%BMD-MF), and tumor-associated parameters [tumor volume (TV), microvessel density (MVD) and stromal proportion (%St)] were measured. The correlation among them was analyzed. Although %BMD-VE and %BMD-MF varied (from 0 to 21.6%, 0 to 29.6%, respectively), depending on the cancer cell line, both parameters were significantly correlated with %St (p < 0.005). Furthermore %BMD-VE and %BMD-MF also significantly correlated (p < 0.005). In order to assess the effect of tumor growth sites on the recruitment of the cells of interest, a human pancreatic cancer cell line, Capan-1, was transplanted into 5 different sites: subcutaneous tissue, peritoneum, liver, spleen and lung. Tumors in the subcutaneous tissue and peritoneum induced desmoplastic stroma (%St = 22.7%, 19.5%, respectively) and contained BMD-VE (%BMD-VE = 21.6%, 16.5% respectively) and BMD-MF (%BMD-MF = 29.6%, 24.5%, respectively), but weak stromal induction without recruitment of BMD-VE or -MF was observed in the tumors at of the liver, spleen and lung (%St = 9.7%, 9.1%, 5.4%, respectively). cDNA microarray analysis identified the 29 genes that expression was especially up- or down-regulated in the cell line that induced an abundant stromal reaction. However they did not encoded the molecules that were directly involved in stromal cell recruitment (chemokines), differentiation (cytokines) or proliferation (growth factors). These results indicate that the recruitment of BMD-VE and -MF is required for stromal formation during cancer progression and that the cancer microenvironment is important in stromal reaction and the recruitment of BMD-VE and -MF. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15729726     DOI: 10.1002/ijc.20969

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma.

Authors:  J Humberto Treviño-Villarreal; Douglas A Cotanche; Rosalinda Sepúlveda; Magda E Bortoni; Otto Manneberg; Taturo Udagawa; Rick A Rogers
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 2.  Targeting stroma to treat cancers.

Authors:  Boris Engels; Donald A Rowley; Hans Schreiber
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

3.  The tumor stromal microenvironment as modulator of malignant behavior.

Authors:  Charlotte Kuperwasser
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12       Impact factor: 2.673

Review 4.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

5.  The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents.

Authors:  Umberto Galderisi; Antonio Giordano; Marco G Paggi
Journal:  World J Stem Cells       Date:  2010-02-26       Impact factor: 5.326

6.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.

Authors:  Moshe Elkabets; Ann M Gifford; Christina Scheel; Bjorn Nilsson; Ferenc Reinhardt; Mark-Anthony Bray; Anne E Carpenter; Karin Jirström; Kristina Magnusson; Benjamin L Ebert; Fredrik Pontén; Robert A Weinberg; Sandra S McAllister
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

7.  Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer.

Authors:  Qian Zhang; Chunwei Peng
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

8.  Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo.

Authors:  Silvestre Vicent; Leanne C Sayles; Dedeepya Vaka; Purvesh Khatri; Olivier Gevaert; Ron Chen; Yanyan Zheng; Anna K Gillespie; Nicole Clarke; Yue Xu; Joseph Shrager; Chuong D Hoang; Sylvia Plevritis; Atul J Butte; E Alejandro Sweet-Cordero
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

9.  Breast cancer by proxy: can the microenvironment be both the cause and consequence?

Authors:  Lone Rønnov-Jessen; Mina J Bissell
Journal:  Trends Mol Med       Date:  2008-12-16       Impact factor: 11.951

Review 10.  Mesenchymal stem cells as vectors for lung disease.

Authors:  Michael R Loebinger; Elizabeth K Sage; Sam M Janes
Journal:  Proc Am Thorac Soc       Date:  2008-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.